lobbying_activities: 3189659
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3189659 | bdc0b9fb-0fa5-4504-bcbe-f8aee0dba04d | Q2 | COMPASS GOVERNMENT RELATIONS PARTNERS, LLC | 401106533 | COALITION FOR INNOVATIVE LABORATORY TESTING, INC. | 2024 | second_quarter | MED | Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA) | 0 | 0 | 2024-07-12T14:25:00-04:00 |